Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) exposed/refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies.

被引：2

作者：

Rodriguez-Otero, Paula

Mateos, Maria-Victoria

Oriol, Albert

Larocca, Alessandra

Blade, Joan

Cavo, Michele

Leleu, Xavier

Nadeem, Omar

Hiemenz, John W.

Hassoun, Hani

Touzeau, Cyrille

Alegre, Adrian

Paner, Agne

Maisel, Christopher

Mazumder, Amitabha

Raptis, Anastasios

Thuresson, Marcus

Harmenberg, Johan

Harlin, Olof

Richardson, Paul G.

机构：

[1] Clin Univ Navarra, Pamplona, Spain

[2] Hosp Clin Univ Salamanca, IBSAL, CIC, Salamanca, Spain

[3] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain

[4] Hosp Badalona Germans Trias & Pujol, Josep Carreras Res Inst, Badalona, Spain

[5] Univ Torino, Azienda Osped Univ Citta Salute & Sci, Div Hematol, Myeloma Unit, Turin, Italy

[6] Hosp Clin Barcelona, IDIBAPS, Hematol Dept, Barcelona, Spain

[7] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[8] CHU Poitiers, Poitiers, France

[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Univ Florida, Dept Med, Div Hematol Oncol, Gainesville, FL USA

[11] Mem Sloan Kettering Canc, Dept Med, Myeloma Serv, New York, NY USA

[12] Univ Hosp, Nantes, France

[13] Univ Nantes, Univ Angers, CNRS, INSERM,CRCINA, Nantes, France

[14] Hosp Univ La Princesa, Madrid, Spain

[15] Hosp Univ Quironsalud, Madrid, Spain

[16] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[17] Baylor Scott & White Charles A Sammons Canc Ctr, Dallas, TX USA

[18] Oncol Inst Hope & Innovat, Glendale, CA USA

[19] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA

[20] Oncopeptides AB, Stockholm, Sweden

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.8048

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8048

引用

页数：4